February 18, 2026

Metsera

1762606518 unnamed file.jpg

Pharma takeover: Pfizer set to acquire Metsera in $10 bn deal; wins board backing after Novo Nordisk exits bidding war

contact@dailyupdatesindia.com02 mins

Pfizer is poised to acquire US-based biotechnology firm Metsera in a $10 billion deal, after winning a heated bidding battle against Danish drugmaker Novo Nordisk, which has now withdrawn from the race, AFP reported.Metsera, which specialises in obesity treatments, said in a statement that Pfizer’s improved offer of $86.25 per share had been unanimously approved…

Read More
1758544100 unnamed file.jpg

Drug expansion: Pfizer ramps up obesity treatments with $4.9B Metsera deal; shares jump sharply

contact@dailyupdatesindia.com01 mins

Pfizer is intensifying its entry into obesity treatments by acquiring development-stage drugmaker Metsera for $4.9 billion, the company announced Monday. The deal values each Metsera share at $47.50 in cash, a premium of more than 42% over Friday’s closing price, according to news agency AP report.Additional payments of $22.50 per share could be triggered depending…

Read More